SANGUI BIOTECH INTERNATIONAL INC Income Statement

Ask AI

Financial Statements

In USD, except per-share amounts

	FY2022 12 months to Jun 30, 2022	FY2021 12 months to Jun 30, 2021	FY2020 12 months to Jun 30, 2020	FY2019 12 months to Jun 30, 2019	FY2018 12 months to Jun 30, 2018
License revenues
COST OF SALES
GROSS MARGIN
OPERATING EXPENSES
Research and development
Professional fees
General and administrative
Depreciation and amortization
Total Operating Expenses
OPERATING LOSS
Gain (Loss) of foreign exchange
Interest expense
Total other income (expense)
OTHER INCOME (EXPENSE)
Loss on out of court settlement
Gain (Loss) on foreign exchange
Interest expense
Loss on Settlement on accounts payable
Total other income (expense)
LOSS BEFORE INCOME TAXES AND NON-CONTROLLING INTEREST
Provision for income taxes
Net loss
Less: Net loss attributable to non-controlling interest
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS
Foreign currency translation adjustments
COMPREHENSIVE LOSS
NUMBER OF SHARES OUTSTANDING
BASIC AND DILUTED LOSS PER SHARE
BASIC AND DILUTED WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING

Comments